The quality of impressions for crowns and bridges: an assessment of the work received at three commercial dental laboratories. assessing qualities of impressions that may lead to occlusal discrepancies with indirect restorations.

There are few published studies that directly assess the quality of impressions for crowns and bridges in the UK. This paper considers aspects of impression quality with particular attention to factors causing potential occlusal discrepancies in the final restoration. To this end three dental laboratories were visited over a 3-month period. All impressions for conventional crown and bridgework that arrived on the days of the visits were examined and assessed against criteria defined on a custom-designed assessment form. A total of 206 impression cases were considered in this study. Flexible impression trays were used for 65% of working impressions. Their use was more common for NHS work than for private work. 31.9% of all alginate impressions examined were not adequately fixed to the tray. Visible contamination of impressions was not uncommon.

The quality of impressions for crowns and bridges: an assessment of the work received at three commercial dental laboratories. assessing the quality of the impressions of prepared teeth.

The literature is limited in studies directly assessing the quality of impressions for crowns and bridges in the UK. The aim of the study was to assess the quality of impressions for conventional crown and bridgework received by commercial dental laboratories. Three dental laboratories were visited over a 3-month period. All impressions for conventional crowns and bridges that arrived on the days of the visits were examined prior to any laboratory processing. A total of 206 impression cases were examined and assessed against criteria laid out in a custom-designed assessment form. Defects were commonly found in the recording of prepared teeth. Overall, 44.2% of impression cases were unsatisfactory. NHS impressions were more than twice as likely to be unsatisfactory compared to private impressions. If the results of this survey are typical then the general quality of impressions for fixed crown and bridgework is unacceptable. This is particularly true for work completed under the NHS contract.

Prevention of artificial dental plaque formation in vitro by plant extracts.

AIMS: A number of previous studies have shown that plant extracts can inhibit formation of dental plaque. The ability of extracts of Rosmarinus officianalis L., Salvia officianalis L., unfermented cocoa, red grape seed and green tea to inhibit plaque bacteria, glucosyltransferase activity, glucan and plaque formation in an in vitro model using bovine teeth was examined. METHODS AND RESULTS: The antimicrobial activity of the plant extracts against oral bacteria was determined using a standard susceptibility agar dilution technique. Inhibition of growth and acid production from glucose and sucrose by Streptococcus mutans in liquid culture was investigated. Prevention of plaque formation on bovine teeth initiated by Strep. mutans was studied using an artificial mouth. The plant extracts inhibited the growth of oral bacteria and prevented acid production by Strep. mutans. Extracts inhibited glucosyltransferase activity and glucan production and inhibited adhesion to glass. Extracts of R. officianalis L. and S. officianalis L. at 0·25 mg ml(-1) reduced plaque growth by >80%. Green tea extract completely inhibited plaque formation but resulted in a greenish discolouration of the teeth which could not be removed by scrubbing. CONCLUSIONS: The plant extracts, particularly those from R. officianalis L. and S. officianalis L., inhibited glucosyltranferase activity, glucan production and plaque formation in vitro. SIGNIFICANCE AND IMPACT OF THE STUDY: The results suggest that the extracts of R. officianalis L. and S. officianalis L. may be useful as antiplaque agents in foods and dental preparations. Bovine teeth can be used as an alternative to hydroxyapatite for studies of plaque formation, but they need to be carefully sterilized before use.

The antibacterial activity of plant extracts containing polyphenols against Streptococcus mutans.

The minimum inhibitory concentrations (MIC) of commercially available and 70% aqueous propanone (P70) extracts from plants chosen for polyphenol content on Streptococcus mutans and other bacteria were determined using a standard susceptibility agar dilution technique to investigate their potential use as anticariogenic agents. The effects on adhesion of S. mutans to glass were also studied. The lowest MICs were for the P70 extracts of red grape skin (0.5 mg ml(-1)) and green tea and sloe berry skin (2 mg ml(-1)). The commercial extracts generally had a lower activity with a minimum MIC of 2 mg ml(-1) for tea extracts, grape seed extracts and Pynogenol (extract of maritime pine). All other extracts had MICs of > or = 4 mg ml(-1). Unfermented cocoa had greater antimicrobial activity than fermented cocoa and the activity of the fractionated extract increased with the extent of epicatechin polymerization. Epicatechin polymer had an MIC of 1 mg ml(-1) and an MBC of 64 mg ml(-1). Selected extracts were tested against other oral bacteria and showed activity against gram-positive organisms. P70 extracts of unfermented cocoa, epicatechin polymer fraction, green tea and red grape seed were bacteriostatic and prevented acid production when added at the MIC to cultures of S. mutans grown in a chemically defined medium supplemented with either glucose or sucrose. There was a reduction in viability which was greater when added to washed cells, but there were some viable cells after 24 h. The extracts also reduced adherence of S. mutans to glass.

Observations on third-stage larvae and adults of Litomosoides carinii (Nematoda: Filarioidea) by scanning and transmission electron microscopy.

The morphology of the body wall of the infective third-stage larvae and adults of Litomosoides carinii was studied by scanning and transmission electron microscopy. The mouth of both stages is surrounded by four inner papillae and two outer papillae; a pair of amphidial glands open laterally between the inner papillae. Female larvae and adults have two lateral caudal papillae; male larvae have a single ventral one, and adult males have two ventro-lateral lines of caudal papillae. The larval cuticle is two-layered, with fibres in the inner layer, whereas the adult cuticle has four layers apparently traversed by channels. Except for the chordal regions, larvae and adults both have an exceptionally thin hypodermis which is separated from both the cuticle and the underlying muscle cells by highly-convoluted membranes. The dorsal and ventral hypodermal chords contain nervous tissue, whereas the lateral hypodermis contains mainly mitochondria, golgi and micro-organisms. The muscle cells of larvae and adults contain thick and thin myofilaments arranged parallel to the long axis of the worms. In larvae each section has nine to 12 muscle cells, each of which has an inner non-sarcoplasmic zone containing the nucleus. The muscle cells of adult worms, although fewer in number, are more complex, and those of male worms in particular have lamellae which are deeply invaginated to form dense rectangular bands. Glycogen and lipid droplets are absent from larval muscle cells, whereas they are present in those of adult worms.

Polyols in confectionery: the route to sugar-free, reduced sugar and reduced calorie confectionery.

Polyol-containing confectionery offers considerable advantages over traditional sucrose-based confectionery in terms of reduced energy content and reduced cariogenicity. However, over-consumption of polyol confectionery may lead to gastrointestinal symptoms in some individuals. Rather than consider this as a distinct disadvantage to the consumer, this article discusses how careful consideration of the physico-chemical properties of polyols and advances in product development and formulation can provide suitable polyol-based products for the consumer. Furthermore. food legislation and ingredient pricing issues are just some of the factors that must be taken into account when designing new polyol-containing products if their functional benefits and good product quality are to be delivered to the consumer.

Improved oral absorption of L-365,260, a poorly soluble drug.

L-365,260, a specific and potent nonpeptide antagonist of the CCKB receptor, is under investigation for its potential utility in the treatment of anxiety and panic disorders. This drug has a very low aqueous solubility (< 2 micrograms mL-1). When L-365,260 was given orally as a suspension in 0.5% methylcellulose (5 mg kg-1), the absorption was rapid but incomplete. The peak concentrations occurred in about 30-40 min, and the bioavailability was 8.6% for the dog and 13.6% for the rat. The poor bioavailability could be attributed to poor absorption or extensive first-pass metabolism. By comparing the drug concentrations in the systemic circulation during portal and femoral (or cephalic) vein infusion, the hepatic first-pass metabolism was estimated to be 0.30 for the rat and 0.14 for the dog, suggesting that first-pass metabolism is not the main reason for the low bioavailability of the drug in rats and dogs. The limited bioavailability is, therefore, more likely due to its poor absorption as a result of its poor aqueous solubility and slow dissolution rate. However, while the absorption was substantially improved when the drug was given orally as a solution in PEG 600 solution, the bioavailability increased threefold to fourfold in rats and sixfold to sevenfold in dogs. Although the underlying mechanism for the improved absorption is unknown, PEG 600 may have exerted a cosolubilizing effect which enhances the dissolution rate of L-365,260 in the GI tract, resulting in better absorption. Kinetic analysis by a deconvolution technique revealed that PEG 600 increased both the extent and rate of absorption. These results are consistent with the notion that absorption of L-365,260 is rate limited by its dissolution rate. The data from these animal studies provides valuable information in selecting the formulation for clinical trials.